400-921-8278
Catalog_no | ADMC1001 |
Product_name | LY2835219 free base (Abemaciclib) |
Category | 抑制剂与激动剂 |
Size | 10mg/50mg/100mg |
Price | 1000.00/2120.00/2660.00 |
Specificity | TargetTargets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. IC50: 2 nM (CDK4), 10 nM (CDK6) |
Dilution | IC50: 2 nM (CDK4), 10 nM (CDK6) |
Purification | >99% |
Concentration | 靶点:CDK;IC50: 2 nM (CDK4), 10 nM (CDK6) |
Storage_stability | 2 years -20°C Powder, 2 weeks4°C in DMSO,6 months-80°C in DMSO |
othername | LY2835219; LY-2835219; LY 2835219 |
Observed_band | 506.6 |
Notes | LY2835219 is an orally available cyclin-dependent kinase (CDK) inhibitor that targets the CDK4 (cyclin D1) and CDK6 (cyclin D3) cell cycle pathway, with potential antineoplastic activity. IC50: 2 nM (CDK4), 10 nM (CDK6) |
Instructions | 查看与下载 |
Share |
Copyright © 2021 苏州博特龙免疫技术有限公司 版权所有 ,苏ICP备2021013855号-1 苏公网安备32050702011981号